Take this 10-question quiz to learn more about interstitial cystitis (IC), its symptoms, causes, and treatments. Designed for the general public, with answers, explanations, and trusted references.

Patients (pts) were randomized 1:1:1 to 30 or 60 mg of daily duloxetine, or daily placebo. Eligible pts had stage II-III CRC and no baseline neuropathy, were ≥ 25 years of age and scheduled to receive ...

Methods: 50 patients of non-metastatic esophageal cancer (ineligible for surgery or those who refused surgery), adenocarcinoma or Squamous cell carcinoma (SqCC), age > 18 years, ECOG PS 0-2, were ...

Perioperative FLOT (fluorouracil, leucovorin, oxaliplatin, and docetaxel) is a standard therapy for resectable gastric and gastroesophageal junction adenocarcinomas, but recurrence rates remain ...

Cancer of unknown primary site encompasses a heterogeneous group of metastatic cancers with an unidentified primary site of origin. Putative site-specific therapy and empirical chemotherapy are acc ...

Pfizer isn’t stopping to smell the roses on its speed run to secure a full FDA approval for its Braftovi combination therapy. | Pfizer's Braftovi, combined with Eli Lilly's Erbitux and chemo ...

AstraZeneca’s immunotherapy Imfinzi has proven it can help certain patients with early-stage stomach cancer, according to results from a phase 3 study. Adding Imfinzi to the chemotherapy regimen ...

NEW YORK, May 30, 2025--Pfizer Inc. (NYSE: PFE) today announced statistically significant and clinically meaningful survival results from the Phase 3 BREAKWATER trial evaluating BRAFTOVI ...

In the 260-patient study, median event-free survival reached 16 months for patients assigned to PAXG, as compared with 10.2 months with the mFOLFIRINOX (5-fluorouracil, leucovorin, irinotecan ...

The standard treatment for stage III colon cancer, regardless of dMMR status, is surgical resection followed by fluoropyrimidine-oxaliplatin chemotherapy (FOLFOX), but about 15% of patients have ...